An emerging fungal threat spread at an alarming rate in US health care facilities, study says
Summary by Ground News
Clinical cases of Candida auris nearly doubled in 2021, according to new data. There was also a tripling of the number of cases resistant to echinocandins, the first-line treatment. The CDC has called Candida Auris an "urgent threat" because it is multidrug-resistant.